Safety Efforts in Pediatric Drug Development
przez
Conor D. Byrne
Brak ocen
Children’s
Format
Twarda okładka
Strony
133
Język
Słoweński
Opublikowany
Jun 1, 2009
Wydawca
Nova Science Pub Inc
Wydanie
1
ISBN-10
1607415658
ISBN-13
9781607415657
Opis
This comprehensive exploration delves into the intricacies of pediatric drug development, focusing on the vital safety measures that underpin the process. It highlights the unique challenges faced when researching and testing medications intended for children, whose physiological and psychological differences from adults necessitate a specialized approach. By examining case studies and regulatory frameworks, it reveals how the pharmaceutical industry strives to ensure that drugs are both effective and safe for younger populations.
The narrative also emphasizes the importance of collaboration among researchers, healthcare professionals, and regulatory bodies. It provides insight into the evolving role of regulations that govern safety testing and how these impact the availability of pediatric medications. This collaborative effort is crucial in advancing knowledge and fostering innovation in drug development for children.
Readers will appreciate the blend of scientific rigor with real-world implications, making this an essential resource for anyone involved in pediatric healthcare, drug development, or regulatory science. The discussions set the stage for informed decision-making in an area where patient safety is paramount.
The narrative also emphasizes the importance of collaboration among researchers, healthcare professionals, and regulatory bodies. It provides insight into the evolving role of regulations that govern safety testing and how these impact the availability of pediatric medications. This collaborative effort is crucial in advancing knowledge and fostering innovation in drug development for children.
Readers will appreciate the blend of scientific rigor with real-world implications, making this an essential resource for anyone involved in pediatric healthcare, drug development, or regulatory science. The discussions set the stage for informed decision-making in an area where patient safety is paramount.
Recenzje
Nie ma jeszcze recenzji
Bądź pierwszy, aby zrecenzować tę książkę i podziel się swoimi przemyśleniami
Dodaj pierwszą recenzjęDziennik czytania
Nie znaleziono dzienników czytania
Zacznij śledzić swój postęp w czytaniu, aby zobaczyć logi tutaj
Dodaj swój pierwszy dziennik czytaniaNotatki
Dziennik transakcji
Nie znaleziono dzienników transakcji
Zacznij śledzić swoje transakcje książkowe, aby zobaczyć logi tutaj
Dodaj swój pierwszy dziennik transakcji